Welcome to the e-CCO Library Archive!
P271
Epidemiological characteristics and factors associated with ulcerative proctitis progression
A. Dimitriu*1, S. Necula1, B. Cotruta1, L. Gheorghe1, C. S. Pop2
1Clinical Institute Fundeni, Department of Gastroenterology, Bucharest, Romania, 2Emergency University Hospital Bucharest, Department of Gastroenterology, Sector 5, Bucharest, Romania
P272
Azathioprine drug monitoring and faecal calprotectin levels in ulcerative colitis
C. Keil*1, L. Püschel1, A. Otte2, M. P. Manns1, O. Bachmann1
1Hannover Medical School, Dept. of Gastroenterology, Hepatology, and Endocrinology, Hannover, Germany, 2University Medical Centre, Institute for Clinical Chemistry, Göttingen, Germany
P273
Risk factors and clinical outcomes associated with cytomegalovirus colitis in patients with acute severe ulcerative colitis
H.-S. Lee*1, H. J. Lee1, H. Seo2, M. Seo2, E. M. Song2, S. W. Hwang2, S. H. Park2, D.-H. Yang2, K.-J. Kim2, B. D. Ye2, J.-S. Byeon2, S.-J. Myung2, S.-K. Yang2
1Asan Medical Centre, University of Ulsan College of Medicine, Health Screening and Promotion Centre, Seoul, South Korea, 2Asan Medical Centre, University of Ulsan College of Medicine, Department of Gastroenterology, Seoul, South Korea
P274
Malignancy in perianal Crohn’s disease
F. Ficari*1, S. Scaringi1, F. Giudici1, D. Zambonin1, C. Di Martino1, F. Tonelli2, P. Bechi1
1Careggi University Hospital, Surgery and Translational Medicine, Florence, Italy, 2University of Florence, Florence, Italy
P275
High incidence of clinically relevant findings at routinely performed bowel ultrasound in asymptomatic inflammatory bowel disease patients
Z. Zelinkova*1, 2, B. Repakova2, B. Kadleckova2
1St Michael’s Hospital, Gastroenterology Department, Bratislava, Slovakia, 2Assiduo, IBD Centre, Bratislava, Slovakia
P276
Faecal calprotectin is well correlated with quantitative faecal immunochemical test in ulcerative colitis but not in infectious colitis
H.-S. Kim*1, J. H. Seong1, H. M. Kim1, J. Kim2
1Yonsei University Wonju College of Medicine, Division of Gastroenterology and Hepatology, Wonju, South Korea, 2Yonsei University Wonju College of Medicine, Departments of Laboratory Medicine, Wonju, South Korea
P277
Prediction of Crohn’s disease activity using contrast-enhanced sonography
M. Białecki1, A. Sławińska1, A. Liebert2, M. Kłopocka*2, Z. Serafin1
1Nicolaus Copernicus University in Toruń, Collegium Medicum in Bydgoszcz, Department of Radiology and Diagnostic Imaging, Bydgoszcz, Poland, 2Nicolaus Copernicus University in Toruń, Collegium Medicum in Bydgoszcz, Chair of Vascular Diseases and Internal Medicine, Bydgoszcz, Poland
P278
Real-time histology at endoscopy: virtual electronic chromoendoscopy and probe confocal laser endomicroscopy can assess fine details of inflammatory changes in ulcerative colitis patients
M. IACUCCI*1, S. Gui X2, A. Oluseyi1, R. Panaccione1, M. Fort Gasia1, S. Ghosh1
1University of Calgary, Gastroenterology, Calgary, Canada, 2University of Calgary, Pathology, Calgary, Canada
P279
Crohn’s disease-associated small bowel carcinomas show distinctive histologic and phenotypic features: an Italian multicentric study
A. Di Sabatino*1, A. Vanoli2, F. Grillo3, C. Mescoli4, G. Nesi5, P. Giuffrida1, C. Papi6, O. Luinetti2, G. Sampietro7, G. Latella8, P. Fociani9, F. Tonelli5, R. Cannizzaro10, L. Coppola6, R. D’Incà4, G. Monteleone11, L. Biancone11, G. Solina12, V. Villanacci13, M. Martino1, A. Orlandi11, A. Rizzo12, M. Salemme13, M. Astegiano14, P. Migliora14, M. Rugge4, R. Fiocca3, G.R. Corazza1, E. Solcia2
1Fondazione IRCCS Policlinico San Matteo, University of Pavia, First Department of Medicine, Pavia, Italy, 2Fondazione IRCCS Policlinico San Matteo, University of Pavia, Department of Molecular Medicine, Pavia, Italy, 3Azienda Ospedaliera Universitaria San Martino, Genova, Italy, 4Azienda Ospedaliera di Padova, Padova, Italy, 5Azienda Ospedaliera Universitaria Careggi, Firenze, Italy, 6Azienda Ospedaliera San Filippo Neri, Roma, Italy, 7Luigi Sacco University Hospital, Surgery Division, Department of Clinical Sciences, Milan, Italy, 8Ospedale San Salvatore, L’Aquila, Italy, 9Luigi Sacco University Hospital, Chair of Pathology, Milan, Italy, 10Centro di Riferimento Oncologico, Aviano, Italy, 11Policlinico Tor Vergata, Roma, Italy, 12Ospedale V. Cervello, Palermo, Italy, 13Spedali Civili di Brescia, Brescia, Italy, 14Azienda Ospedaliera Universitaria Città della Salute e della Scienza, Torino, Italy
P280
Endoscopic training leads to a significant increase in agreement of endoscopic scoring for inflammatory bowel disease: results of the IGIBDEndo educational project
M. Daperno*1, M. Comberlato2, F. Bossa3, L. Biancone4, A. Bonanomi5, A. Cassinotti6, R. Cosintino7, R. Mangiarotti7, G. Lombardi8, A. Papa9, R. Pica10, M. Rabagliati11, L. Grassano11, M. Gasparini11, G. Pagana11, R. D’Incà12, A. Orlando13, F. Rizzello14
1AO Ordine Mauriziano, Gastroenterology Unit, Torino, Italy, 2Ospedale di Bolzano, Gastroenterology Unit, Bolzano, Italy, 3IRCCS ‘Casa Sollievo della Sofferenza’ Hospital, Department of Gastroenterology, San Giovanni Rotondo, Italy, 4Tor Vergata University, Gastroenterology Department, Roma, Italy, 5AOU-Careggi, Gastroenterology, Firenze, Italy, 6Luigi Sacco University Hospital, Gastroenterology Department, Milano, Italy, 7S. Camillo-Forlanini Hospital, Gastroenterology Unit, Roma, Italy, 8AORN Cardarelli, Gastroenterology Unit, Napoli, Italy, 9Complesso Integrato Columbus, Internal Medicine, Roma, Italy, 10ASL Roma B, Ospedale Pertini, Gastroenterology Unit, Roma, Italy, 11ISMB and Politecnico di Torino, Torino, Italy, 12Azienda Ospedaliera di Padova, Department of Surgery, Oncology and Gastroenterology, Padova, Italy, 13AO Ospedali Riuniti Villa Sofia-Cervello, Internal Medicine, Palermo, Italy, 14AO S. Orsola-Malpighi & University, Internal Medicine, Bologna, Italy
P281
One simple question is sufficient for measuring medication adherence in inflammatory bowel disease patients using self-report
M. Severs*1, M.-J. Mangen2, H. H. Fidder1, M. E. van der Valk1, M. van der Have1, A. A. van Bodegraven3, 4, C. H. M. Clemens5, G. Dijkstra6, J. M. Jansen7, D. J. de Jong8, N. Mahmmod9, P. C. van de Meeberg10, A. E. van der Meulen- de Jong11, M. Pierik12, C. Y. Ponsioen13, M. J. L. Romberg- Camps3, P. D. Siersema1, J. R. Vermeijden14, J. van der Woude15, P. N. Zuithoff16, B. Oldenburg1
1University Medical Centre Utrecht, Gastroenterology and Hepatology, Utrecht, Netherlands, 2University Medical Centre Utrecht, Julius Centre for health sciences and primary care, Utrecht, Netherlands, 3ORBIS medical Centre, Gastroenterology and Hepatology, Sittard, Netherlands, 4VU medical Centre, Gastroenterology and Hepatology, Amsterdam, Netherlands, 5Diaconessenhuis, Gastroenterology and Hepatology, Leiden, Netherlands, 6University Medical Centre Groningen, Gastroenterology and Hepatology, Groningen, Netherlands, 7Onze Lieve Vrouwe Gasthuis, Gastroenterology and Hepatology, Amsterdam, Netherlands, 8University Medical Centre st. Radboud, Gastroenterology and Hepatology, Nijmegen, Netherlands, 9Antonius Hospital, Gastroenterology and Hepatology, Nieuwegein, Netherlands, 10Slingeland Hospital, Gastroenterology and Hepatology, Doetinchem, Netherlands, 11Leiden University Medical Centre, Gastroenterology and Hepatology, Leiden, Netherlands, 12University Medical Centre Maastricht, Gastroenterology and Hepatology, Maastricht, Netherlands, 13Academic Medical Centre Amsterdam, Gastroenterology and Hepatology, Amsterdam, Netherlands, 14Meander Medical Centre, Gastroenterology and Hepatology, Amersfoort, Netherlands, 15Erasmus Medical Centre, Gastroenterology and Hepatology, Rotterdam, Netherlands, 16University Medical Centre Utrecht, Julius Centre for Health Sciences and Primary Care, Utrecht, Netherlands
P282
The long-term effect of biologics in newborns
B. Truta*, J. Canner, J. Efron, B. Safar
Johns Hopkins University, Baltimore, United States
P283
Development, validation and clinical application of a novel tool to measure disease-related knowledge in patients with inflammatory bowel disease: IBD-KNOW
H. Yoon*1, S.-K. Yang2, H. So2, K. E. Lee3, S. H. Park2, S.-A. Jung3, C. M. Shin1, Y. S. Park1, N. Kim1, D. H. Lee1
1Seoul National University Bundang Hospital, Internal Medicine, Seongnam-si, South Korea, 2Department of Gastroenterology, Asan Medical Centre, University of Ulsan College of Medicine, Seoul, South Korea, 3Department of Internal Medicine, Ewha Woman’s University School of Medicine, Seoul, South Korea
P284
Jejunal Crohn’s disease: characteristics, detection rate, outcome, and need of immunomodulators in a retrospective single-centre study
A. Ruffa1, C. Petruzziello2, E. Angelucci3, G. Sica4, S. Onali3, A. Rossi2, E. Calabrese2, E. Lolli3, F. Pallone3, L. Biancone*5
1University ‘Tor Vergata’ of Rome, Department of Systems Medicine, Rome, Italy, 2University ‘Tor Vergata’ of Rome, Italy, Department of Systems Medicine, Rome, Italy, 3University ‘Tor Vergata’ of Rome, Department of Systems Medicine, Roma, Italy, 4University ‘Tor Vergata’ of Rome, Surgery, Roma, Italy, 5University, Department of Systems Medicine, Rome, Italy
P285
Extraintestinal manifestations of Crohn’s disease have a major influence on anxiety levels and coping skills
D. Schwartz*1, E. Chernin2, D. Greenberg2, O. Sarid2, V. Slonim-Nevo2, M. Friger2, H. Vardi2, S. Odes2
1Soroka UMC, Gastroenterology, Beer Sheva, Israel, 2Ben Gurion University, Beer Sheva, Israel
P286
Long-term follow-up of polypoid dysplasia and assessment of peri-polyp biopsies of flat mucosa in patients with inflammatory bowel disease-colitis
N. Krugliak Cleveland*, D. Huo, F. Sadiq, A. Sofia, J. Marks, D. Rubin
University of Chicago Medicine, Inflammatory Bowel Disease Centre, Chicago, Illinois, United States
P287
Differentiating neoplasic and non-neoplasic raised lesions (polyps and pseudopolyps) in long-standing ulcerative colitis: results from a prospective systematic study using virtual chromoendoscopy with i-SCAN and the Kudo classification
A. Cassinotti*1, S. Ardizzone1, P. Fociani2, M. Nebuloni2, P. Molteni1, G. Maconi1, S. Carmagnola1, A. Dell’Era1, A. Massari1, R. de Franchis1, P. Gambitta3
1Luigi Sacco University Hospital, Gastroenterology Unit, Milan, Italy, 2Luigi Sacco University Hospital, Pathology Unit, Milan, Italy, 3Luigi Sacco University Hospital, Endoscopy Unit, Milan, Italy
P288
A real-world study of outcomes in biologic-naïve patients with Crohn’s disease and ulcerative colitis initiating vedolizumab
M. Raluy*1, N. Alam1, R. Donaldson1, M. Smyth2, J. M. Khalid2
1Evidera, Hammersmith, United Kingdom, 2Takeda, London, United Kingdom
P289
Cytomegalovirus reactivation in ulcerative colitis is related to severe inflammatory activity
E. Zagorowicz*1, M. Bugajski*1, A. Mróz2, A. Pietrzak1, A. Magdziak3, P. Wieszczy4
1Institute of Oncology, Gastroenterology, Warsaw, Poland, 2Institute of Oncology, Histopathology, Warsaw, Poland, 3Institute of Oncology, Microbiology, Warsaw, Poland, 4Medical Centre for Postgraduate Education, Warsaw, Poland
P290
Pre-operative anti-glycan antibodies and anti-glycan antibodies developing after pouch surgery in patients with ulcerative colitis correlate with pouch complications: a prospective longitudinal case series
I. Goren*1, L. Yahav2, H. Tulchinsky3, 4, I. Dotan4, 5
1Tel Aviv medical Centre, IBD Centre, Department of Gastroenterology and Liver Diseases, Tel Aviv Sourasky Medical Centre, Tel Aviv, Israel, 2Tel Aviv Medical Centre, IBD Centre, Department of Gastroenterology and Liver Diseases, Tel Aviv Sourasky Medical Centre, Tel Aviv, Israel, 3Sackler Faculty of Medicine, Tel Aviv Israel, Department of Surgery, Tel Aviv Sourasky Medical Centre, Tel Aviv, Israel, 4Tel Aviv medical Centre, Tel Aviv Israel, Pouch clinic, IBD Centre, Tel Aviv, Israel, 5Sackler Faculty of Medicine, Tel Aviv Israel, IBD Centre, Department of Gastroenterology and Liver Diseases, Tel Aviv Sourasky Medical Centre, Tel Aviv, Israel